ClinicalTrials.Veeva

Menu
C

Centrum Medyczne ALL-MED Badania Kliniczne | Krakow, Poland

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Clascoterone
Rocatinlimab
CDX-0159
Upadacitinib
ABP 654
Ruxolitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 6 total trials

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations.

Active, not recruiting
Asthma
Drug: Placebo
Drug: Rocatinlimab

The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children and adolescents (6 to \<18 Years Old) with moderate at...

Enrolling
Atopic Dermatitis
Drug: Vehicle Cream
Drug: Ruxolitinib

Alopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss. AA usually affects the head and fa...

Enrolling
Alopecia Areata
Drug: Placebo
Drug: Upadacitinib

The purpose of this Phase 3, randomized, double-blind, placebo-controlled study is to assess the activity and safety of barzolvolimab compared to pla...

Enrolling
Cold-Induced Urticaria
Chronic Inducible Urticaria
Drug: Barzolvolimab
Drug: Matching Placebo

Trial sponsors

Amgen logo
AbbVie logo
C
Celldex Therapeutics logo
Incyte logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems